SC
Saturna Capital’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,779
| Closed | -$459K | – | 159 |
|
2024
Q3 | $459K | Hold |
9,779
| – | – | 0.01% | 127 |
|
2024
Q2 | $528K | Sell |
9,779
-1,151
| -11% | -$62.2K | 0.01% | 124 |
|
2024
Q1 | $745K | Hold |
10,930
| – | – | 0.01% | 121 |
|
2023
Q4 | $684K | Buy |
+10,930
| New | +$684K | 0.01% | 121 |
|
2023
Q3 | – | Sell |
-3,733
| Closed | -$210K | – | 175 |
|
2023
Q2 | $210K | Buy |
+3,733
| New | +$210K | ﹤0.01% | 160 |
|
2021
Q4 | – | Sell |
-1,880
| Closed | -$210K | – | 175 |
|
2021
Q3 | $210K | Buy |
1,880
+100
| +6% | +$11.2K | ﹤0.01% | 168 |
|
2021
Q2 | $288K | Buy |
+1,780
| New | +$288K | 0.01% | 156 |
|
2021
Q1 | – | Sell |
-13,000
| Closed | -$1.99M | – | 167 |
|
2020
Q4 | $1.99M | Sell |
13,000
-1,200
| -8% | -$184K | 0.05% | 86 |
|
2020
Q3 | $1.19M | Hold |
14,200
| – | – | 0.03% | 94 |
|
2020
Q2 | $1.04M | Buy |
+14,200
| New | +$1.04M | 0.03% | 100 |
|
2020
Q1 | – | Sell |
-3,400
| Closed | -$207K | – | 180 |
|
2019
Q4 | $207K | Buy |
+3,400
| New | +$207K | 0.01% | 184 |
|